Skip to main content

Table 2 Antibiotyping of S. aureus isolates (MSSA and MRSA) from KZN province, South Africa.

From: Antimicrobial susceptibility patterns and characterization of clinical isolates of Staphylococcus aureus in KwaZulu-Natal province, South Africa

MRSA (n = 61)

No. of MRSA (%)**

Antibiotype*

Resistance patterns

 
 

PEN

GM

EM

TE

TM

CIP

MUP

CHL

RF

 

1

+

+

+

+

+

+

+

+

 

4 (6.6)

2

+

+

+

+

+

+

  

+

1 (1.6)

3

+

+

+

+

+

 

+

 

+

3 (4.9)

4

+

+

+

+

+

  

+

+

4 (6.6)

5

+

+

+

+

+

+

+

  

6 (9.8)

6

+

+

 

+

+

  

+

+

2 (3.3)

7

+

+

 

+

+

 

+

 

+

2 (3.3)

8

+

+

+

+

+

   

+

25 (41.0)

9

+

+

+

+

    

+

1 (1.6)

10

+

+

 

+

+

   

+

5 (8.2)

11

+

  

+

    

+

2 (3.3)

12

+

+

+

      

6 (9.8)

MSSA (n = 166)

 
 

PEN

GM

EM

TE

TM

CIP

MUP

CHL

RF

 

1

+

+

+

 

+

    

1 (0.6)

2

+

 

+

+

 

+

   

1 (0.6)

3

+

 

+

+

+

    

4 (2.4)

4

+

 

+

 

+

    

1 (0.6)

5

+

 

+

    

+

 

1 (0.6)

6

   

+

+

 

+

  

1 (0.6)

7

+

 

+

+

     

2 (1.2)

8

+

  

+

+

    

3 (1.8)

9

+

+

  

+

    

5 (3.0)

10

+

       

+

1 (0.6)

11

+

  

+

     

2 (1.2)

12

+

   

+

    

3 (1.8)

13

+

 

+

      

9 (5.4)

14

+

        

114 (68.7)

15

SUSCEPTIBLE TO ALL ANTIBIOTICS

18 (10.8)

  1. KEY
  2. PEN: Penicillin; GEN: Gentamicin; EM: Erythromycin; TE: Tetracycline; TM: Trimethoprim; CIP: Ciprofloxacin; MUP: Mupirocin (5 μg); CHL: Chloramphenicol; RF: Rifampicin.
  3. * Number of antibiotypes in MRSA and MSSA isolates.
  4. ** Percentages in parentheses are based on the total number of isolates in each group (MRSA n = 61; MSSA n = 166).